Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 542

1.

Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Grubb RL 3rd, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL Jr; PLCO Project Team..

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):748-51. doi: 10.1158/1055-9965.EPI-08-0938. Epub 2009 Mar 3.

2.

Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in Japan.

Kubota Y, Seike K, Maeda S, Shinohara Y, Iwata M, Sugimoto N.

Int J Urol. 2011 Jan;18(1):72-5. doi: 10.1111/j.1442-2042.2010.02667.x. Epub 2010 Nov 18.

3.

Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.

Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ.

Urology. 2008 May;71(5):787-91. doi: 10.1016/j.urology.2007.11.036. Epub 2008 Feb 11.

PMID:
18267334
4.

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

Culp S, Porter M.

BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x. Epub 2009 Jun 12.

5.

Obesity and screening PSA levels among men undergoing an annual physical exam.

Rundle A, Neugut AI.

Prostate. 2008 Mar 1;68(4):373-80. doi: 10.1002/pros.20704.

PMID:
18189231
6.

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

Hutterer G, Perrotte P, Gallina A, Walz J, Jeldres C, Traumann M, Suardi N, Saad F, Bénard F, Valiquette L, McCormack M, Graefen M, Montorsi F, Karakiewicz PI.

Eur J Cancer. 2007 May;43(7):1180-7. Epub 2007 Feb 9.

PMID:
17292604
7.

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Freedland SJ, Sun L, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Moul JW, Aronson WJ.

BJU Int. 2008 Sep;102(8):969-74. doi: 10.1111/j.1464-410X.2008.07934.x. Epub 2008 Aug 7.

8.

[Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].

Wang Y, Zhou Z, Tian Y, Shao Q, Chen S, Hong BF, Zhang XH, Ren XH, Sun WX, Wang ZW, Na YQ.

Zhonghua Yi Xue Za Zhi. 2009 Jun 23;89(24):1681-3. Chinese.

PMID:
19957525
9.

Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.

Li F, Shen Z, Lu Y, Yun J, Fan Y.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1731-4. doi: 10.1158/1055-9965.EPI-12-0589. Epub 2012 Jul 31.

10.

Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.

Chia SE, Lau WK, Chin CM, Tan J, Ho SH, Lee J, Cheng C.

BJU Int. 2009 Jun;103(11):1487-91. doi: 10.1111/j.1464-410X.2008.08246.x. Epub 2008 Dec 8.

11.

Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.

Freedland SJ, Platz EA, Presti JC Jr, Aronson WJ, Amling CL, Kane CJ, Terris MK.

J Urol. 2006 Feb;175(2):500-4; discussion 504.

PMID:
16406980
12.

[Impact of obesity on PSA in prostate cancer screening].

Larré S, Azzouzi AR, Cancel-Tassin G, Cormier L, Villette JM, Hoffmann P, Drelon I, Baschet F, Mangin P, Cussenot O.

Prog Urol. 2007 Jun;17(4):815-8. French.

PMID:
17633992
13.

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK; PLCO Project Team..

J Natl Cancer Inst. 2005 Mar 16;97(6):433-8.

PMID:
15770007
14.

Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.

Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK.

J Urol. 2006 Apr;175(4):1286-90; discussion 1290.

PMID:
16515981
15.

Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial.

Pinsky PF, Kramer BS, Crawford ED, Grubb RL, Urban DA, Andriole GL, Chia D, Levin DL, Gohagan JK.

Urology. 2006 Aug;68(2):352-6.

PMID:
16904451
16.

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Project Team..

J Urol. 2005 Mar;173(3):746-50; discussion 750-1.

PMID:
15711261
17.

Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006.

Ando R, Nagaya T, Hashimoto Y, Suzuki S, Itoh Y, Umemoto Y, Ikeda N, Tozawa K, Kohri K, Tokudome S.

Urology. 2008 Sep;72(3):561-5. doi: 10.1016/j.urology.2008.04.008. Epub 2008 Jun 2.

PMID:
18514773
18.

Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.

Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1302-8. doi: 10.1016/j.ijrobp.2007.11.073. Epub 2008 Feb 11.

PMID:
18262732
19.

Body mass index and cancer screening in older American Indian and Alaska Native men.

Muus KJ, Baker-Demaray T, McDonald LR, Ludtke RL, Allery AJ, Bogart TA, Goldberg J, Ramsey SD, Buchwald DS.

J Rural Health. 2009 Winter;25(1):104-8. doi: 10.1111/j.1748-0361.2009.00206.x.

PMID:
19166569
20.

Relationship between prostate-specific antigen and hematocrit: does hemodilution lead to lower PSA concentrations in men with a higher body mass index?

Ohwaki K, Endo F, Muraishi O, Hiramatsu S, Yano E.

Urology. 2010 Mar;75(3):648-52. doi: 10.1016/j.urology.2009.06.099. Epub 2009 Oct 24.

PMID:
19854477

Supplemental Content

Support Center